ClearBridge Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $47.3M | Sell |
|
|||||
|
2025
Q2 | $43M | Hold |
|
|||||
|
2025
Q1 | $37.9M | Buy |
|
|||||
|
2024
Q4 | $43.6M | Hold |
|
|||||
|
2024
Q3 | $36.8M | Sell |
|
|||||
|
2024
Q2 | $46.9M | Hold |
|
|||||
|
2024
Q1 | $47M | Hold |
|
|||||
|
2023
Q4 | $44.9M | Buy |
|
|||||
|
2023
Q3 | $35.1M | Hold |
|
|||||
|
2023
Q2 | $29.4M | Buy |
|
|||||
|
2023
Q1 | $25.4M | Hold |
|
|||||
|
2022
Q4 | $30M | Hold |
|
|||||
|
2022
Q3 | $26.6M | Hold |
|
|||||
|
2022
Q2 | $24.4M | Sell |
|
|||||
|
2022
Q1 | $23.5M | Hold |
|
|||||
|
2021
Q4 | $21.4M | Sell |
|
|||||
|
2021
Q3 | $24.2M | Sell |
|
|||||
|
2021
Q2 | $24.5M | Sell |
|
|||||
|
2021
Q1 | $24.5M | Buy |
|
|||||
|
2020
Q4 | $20.3M | Sell |
|
|||||
|
2020
Q3 | $21.1M | Buy |
|